Quest Diagnostics
DGX
#1104
Rank
โ‚น1.931 T
Marketcap
โ‚น17,270
Share price
-0.83%
Change (1 day)
22.48%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น782.40. In 2024 the company made an earnings per share (EPS) of โ‚น704.52 an increase over its 2023 EPS that were of โ‚น687.31.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.046.04%
2024โ‚น704.522.5%
2023โ‚น687.31-5.83%
2022โ‚น729.87-49.21%
2021โ‚น1,43749.72%
2020โ‚น959.8866.67%
2019โ‚น575.9318%
2018โ‚น488.09-4.26%
2017โ‚น509.8223.19%
2016โ‚น413.84-7.11%
2015โ‚น445.5328.46%
2014โ‚น346.83-31.61%
2013โ‚น507.1160.46%
2012โ‚น316.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น928.19 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น64.45-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.69-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น169.22-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.02-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA